| Patient | Fannie Lou Hamer |
|---|---|
| Date of birth | 1917-10-06 |
| Identifiers | MRN HR-ML031-SYN-TD; SSN (made up) 000-31-2479 |
| Document date | 1967-03-23 |
| Author | Lorraine Batiste-Hill, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Two-week review of home blood pressure readings and the repeat urine test, with a kidney ultrasound and a nephrology telehealth consultation. [S]
Mrs. Hamer returns two weeks after her first visit. She took her home blood pressure twice a day for seven days with the cuff the health center gave her, and the community health worker helped her write the readings down; they average 152/94. Her thirst and frequent urination are already less on metformin, with some loose stools in the first week that have settled. She had her kidney ultrasound this morning at the health center, after the sonographer explained each step; she asked for her companion to stay in the room, and she did. She then spoke with Dr. Agbaje of nephrology by video from the clinic, with the community health worker beside her. Her SNAP and energy assistance applications have been sent. She asked why she needs two new medicines and what they will cost. [S]
| Element | Detail |
|---|---|
| Home blood pressure | Average 152/94 over seven days |
| Metformin | Loose stools the first week, now settled; thirst less |
| Kidney ultrasound | This morning, with her consent and a companion present |
| Benefits | SNAP and energy assistance applications sent |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever; less thirst |
| Cardiovascular | Negative | No chest pain or ankle swelling |
| Gastrointestinal | Negative | Loose stools settled |
| Genitourinary | Negative | Urinating less often; no burning |
| Musculoskeletal | Positive | Leg and back aching after long days |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Metformin extended-release 500 mg oral tablet, one tablet with the evening meal for one week, then two tablets with the evening meal | Two tablets with the evening meal (after one week of one tablet) | Oral route | 1967-03-09 to 1967-07-13 | completed | S |
| Atorvastatin 40 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1967-03-09 | active | S |
| Amlodipine 5 mg and benazepril 20 mg combined oral capsule, one capsule daily | One capsule daily | Oral route | 1967-03-23 | active | S |
| Dapagliflozin 10 mg oral tablet, one tablet daily; stop on days of vomiting, diarrhea or not eating, and before surgery | One tablet daily, with sick-day rules | Oral route | 1967-03-23 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1967-03-23 | Body height | 163 | cm | S |
| 1967-03-23 | Body weight | 92.6 | kg | S |
| 1967-03-23 | Body mass index (BMI) [Ratio] | 34.9 | kg/m2 | S |
| 1967-03-23 | Systolic blood pressure | 156 | mm[Hg] | S |
| 1967-03-23 | Diastolic blood pressure | 96 | mm[Hg] | S |
| 1967-03-23 | Heart rate | 82 | /min | S |
| 1967-03-23 | Respiratory rate | 16 | /min | S |
| 1967-03-23 | Body temperature | 36.7 | Cel | S |
| 1967-03-23 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1967-03-23 | Albumin/Creatinine [Mass Ratio] in Urine | 96 | mg/g | Below 30 mg/g normal (A1); 30 to 300 moderately increased (A2) | High | S |
Vital signs recorded on 1967-03-23; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Consent and chaperone | Blood pressure, heart, lung and ankle examination explained and agreed; female nurse present |
| General | Well; blood pressure 156/96 (average of two readings), pulse 82 |
| Cardiovascular | Regular rhythm; no murmur; no ankle swelling |
| Respiratory | Clear |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Type 2 diabetes with hyperglycemia, newly diagnosed: A1c 8.6% and random glucose 238 mg/dL with thirst and frequent urination; synthetic modern episode linked to the diabetes documented in her later life | active | confirmed | E11.65 | S — Synthetic modern diagnosis; diabetes is documented only at the end of her life. |
| Elevated blood pressure at intake (164/98 mmHg), without a diagnosis of hypertension; home readings for one week to confirm | resolved | confirmed | R03.0 | S — Synthetic presenting finding, superseded by the confirmed diagnosis at two weeks. |
| Albumin in the urine (urine albumin-to-creatinine ratio 88 mg/g) and eGFR 73, in a woman whose kidneys were injured in a beating years ago; to be repeated and investigated | resolved | confirmed | R80.9 | S — Synthetic presenting finding, superseded by the kidney diagnosis at two weeks; the old kidney injury is documented. |
| Hypertension, stage 2, confirmed by home readings (average 152/94 mmHg), with chronic kidney disease; synthetic modern episode linked to the hypertension reported in her later life | active | confirmed | I12.9 | S — Synthetic modern diagnosis; hypertension is reported only at the end of her life. |
| Chronic kidney disease G2 A2 (eGFR 73, albumin-to-creatinine ratio 88 to 96 mg/g), with a small, scarred right kidney on ultrasound consistent with old injury; diabetes and high blood pressure likely contribute | active | confirmed | N18.2 | S — Synthetic kidney findings anchored to the documented permanent kidney damage. |
| Type 2 diabetes with diabetic chronic kidney disease (coded with the kidney disease by convention) | active | confirmed | E11.22 | S — Synthetic modern coding. |
| Food insecurity: food runs out before the end of most months | active | confirmed | Z59.41 | S — Synthetic social need found on the screen. |
| Transportation insecurity: no car; the health center is a long drive away and rides are hard to arrange | active | confirmed | Z59.82 | S — Synthetic social need anchored to her rural Delta home. |
| Hyperlipidemia: LDL 146 mg/dL | active | confirmed | E78.5 | S — Synthetic laboratory finding. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Consent and chaperone for every examination, test and procedure | Every visit | Completed today | Ultrasound, blood pressure, examination, vaccines and blood tests each explained and agreed; companion present for the ultrasound at her request |
| Examination | Clinic blood pressure (seated, two readings, large cuff) | Every visit | Completed today | 156/96 |
| Self-management | Home blood pressure readings | Seven days to confirm the diagnosis; then twice a week, and daily for a week after any change | Completed today | Seven-day average 152/94 confirms hypertension |
| Examination | Weight and BMI | Every visit | Completed today | 92.6 kg, BMI 34.9 |
| Laboratory | Potassium, creatinine and eGFR | One to two weeks after starting an ACE inhibitor, then every 6 months (more often with changes) | Ordered | Benazepril started today; check booked in one to two weeks |
| Laboratory | Urine albumin-to-creatinine ratio | Repeat to confirm; 3 to 6 months after a treatment change; then every 6 months while moderately increased | Completed today | 96 mg/g, confirming the intake result of 88 |
| Imaging | Kidney ultrasound | Once, for reduced kidney function with an old injury | Completed today | Small scarred right kidney; normal left kidney; no blockage |
| Laboratory | Hemoglobin A1c | Every 3 months until at goal, then every 6 months | Up to date | 8.6% at intake; next in three months |
| Laboratory | Lipid panel | 4 to 12 weeks after starting a statin, then yearly | Up to date | LDL 146 at intake; atorvastatin started at intake; recheck at four to twelve weeks |
| Examination | Baseline ECG and TSH | At the diagnosis of hypertension | Up to date | Done at intake: sinus rhythm without left ventricular hypertrophy; TSH 2.1 |
| Medication safety | Medicine safety: low blood sugar, sick-day rules, genital infections, cough, swelling, adherence and cost | Every visit | Completed today | Loose stools on metformin settled; sick-day rules for dapagliflozin and benazepril explained and written down; cost checked with the pharmacist |
| Medication safety | Pneumococcal, hepatitis B and Tdap vaccines | Once (hepatitis B as two doses a month apart) | Completed today | PCV20, hepatitis B dose 1 and Tdap given after she agreed |
| Survey | Social needs screen (AHC-HRSN) and resources | At intake, then every few months while needs are open | Completed today | Food, transportation and utility needs from intake; SNAP and energy assistance applications sent; pantry and produce program started |
| Referral | Nephrology review | At diagnosis; then by telehealth if albumin stays raised | Completed today | Seen by Dr. Agbaje by telehealth today |
Goal progress:
Immunizations given today: Pneumococcal conjugate vaccine PCV20; Hepatitis B vaccine (HepB-CpG), dose 1 of 2; Tetanus, diphtheria, and acellular pertussis vaccine (Tdap) [S]
Guideline basis: Introduction and Methodology: Standards of Care in Diabetes-2026 (2026); 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2026 (2026); 1. Improving Care and Promoting Health in Populations: Standards of Care in Diabetes-2026 (2026); 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2025); KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024); CMID: Clinical Monitoring Intelligence Database, hypertension, diabetes type 2, hyperlipidemia, chronic kidney disease and depression monographs (2026); Trauma-Informed Care in Behavioral Health Services (Treatment Improvement Protocol 57) (2014); Code of Medical Ethics Opinion 2.1.1: Informed Consent (2026); The Accountable Health Communities Health-Related Social Needs Screening Tool (2017); Adult Immunization Schedule by Age (2026)
Follow-up: Potassium and creatinine in one to two weeks at the health center, with a ride. Review in six weeks with lipids, retinal photographs and the second hepatitis B dose. Call for dizziness, ankle swelling, a cough that will not stop, swelling of the lips or tongue (call 911), or vomiting that stops her drinking. Next scheduled visit 1967-05-04: six-week review: blood pressure, kidney function and potassium after the new medicines, lipids, retinal photographs, and benefits. [S]